期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Gallbladder function and dynamics of bile flow in asymptomatic gallstone disease 被引量:8
1
作者 Sevim Süreyya eri Feride Meltem zbek +6 位作者 Celal eri Bahattin Baykal Hasan Erol Eroglu Zeynep Baykal Mustafa Yildiz Semahat Saglam Ahmet Yesildag 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第22期2763-2767,共5页
AIM: To investigate the effects of gallbladder stones on motor functions of the gallbladder and the dynamics of bile flow in asymptomatic gallstone disease. METHODS: Quantitative hepatobiliary scintigraphy was perfo... AIM: To investigate the effects of gallbladder stones on motor functions of the gallbladder and the dynamics of bile flow in asymptomatic gallstone disease. METHODS: Quantitative hepatobiliary scintigraphy was performed to detect the parameters of gallbladder motor function [gallbladder ejection fraction (GBEF), gallbladder visualization time (GBVT), gallbladder time to peak activity (GBTmax), gallbladder half emptying time (GBT1/2), and transit time of bile to duodenum (TTBD)] in 24 patients with asymptomatic cholelithiasis who were diagnosed incidentally during routine abdominal ultrasonographic examination and 20 healthy subjects with normal gallbladder. RESULTS: Even though there was no significant difference in the clinical and laboratory parameters between the patient and control groups, all parameters of gallbladder function except TTBD were found to differ significantly between the two groups. GBEF in the patient group was decreased (P = 0.000) and GBVT, GBT GBT1/2 in the patient group were longer (P = 0.000, P = 0.015, P = 0.001, respectively).there were not any clinical and laboratory findings, gallbladder filling and emptying could be impaired in patients with gallstone disease. 展开更多
关键词 asymptomatic gallstone disease Hepatobiliary scintigraphy Gallbladder function
下载PDF
Prevention of Coronary Heart Disease: A Translational Clinical Challenge 被引量:3
2
作者 Julie Giannini Janae Padilla +2 位作者 Robert Philip Eaton Kristen Gonzales David S. Schade 《World Journal of Cardiovascular Diseases》 2022年第1期11-23,共13页
<strong>Introduction:</strong><span style="white-space:normal;font-family:;" "=""> Atherosclerotic cardiovascular disease is a dysmetabolic medical condition resulting i... <strong>Introduction:</strong><span style="white-space:normal;font-family:;" "=""> Atherosclerotic cardiovascular disease is a dysmetabolic medical condition resulting in the #1 cause of morbidity and mortality in the United States. Coronary Artery Calcium (CAC)</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:;" "="">CT non-invasively identifies athe</span><span style="white-space:normal;font-family:;" "="">rosclerosis in asymptomatic individuals. This translational study tested the hypothesis that clinically overt</span><span style="white-space:normal;font-family:;" "=""></span><span style="white-space:normal;font-family:;" "="">cardiovascular disease can be prevented in asymptomatic individuals in a medical clinic. <b>Methods:</b> Two hundred </span><span style="white-space:normal;font-family:;" "="">and </span><span style="white-space:normal;font-family:;" "="">six</span><span style="white-space:normal;font-family:;" "=""> asymptomatic adults requested a CAC scan to identify subclinical heart disease. Individuals with a positive CAC score ></span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:;" "="">1 (n = 125) were prescribed targeted</span><span style="white-space:normal;font-family:;" "=""> medical therapy to reverse their atherosclerosis. The goal was to achieve an LDL Cholesterol (LDL-C) ≤</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:;" "="">60 mg/dl. One hundred </span><span style="white-space:normal;font-family:;" "="">and </span><span style="white-space:normal;font-family:;" "="">ten individuals</span><span style="white-space:normal;font-family:;" "=""> reached this goal (67 male, 43 female) receiving 10 mg/d of rosuvastatin and 10 mg/d of ezetimibe plus a low cholesterol diet. Other fifteen individuals with positive CAC scores did not achieve this LDL-C goal. <b>Results:</b> In the group following medical therapy and achieving an LDL-C ≤</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:;" "="">60 mg/dl, no cardiovascular events</span><span style="white-space:normal;font-family:;" "=""> were observed during a maximum observation period of 5 years (mean observation time = 3.6 years). Based on previously published CVD outcome data in individuals with similar CAC scores, 12.6 cardiovascular events were expected. Two of fifteen individuals with positive CAC scores not following medical therapy had a cardiovascular event. None of the 81 individuals </span><span style="white-space:normal;font-family:;" "="">with a </span><span style="white-space:normal;font-family:;" "="">zero score had a cardiovascular event during follow-up. No adverse effects of therapy occurred. <b>Conclusion:</b> In a medical</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:;" "="">clinic</span><span style="white-space:normal;font-family:;" "="">,</span><span style="white-space:normal;font-family:;" "=""> adult population with positive CAC scores</span><span style="white-space:normal;font-family:;" "=""> and an LDL-C ≤</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:;" "="">60</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:;" "="">mg/dl, targeted medical therapy prevented overt</span><span style="white-space:normal;font-family:;" "=""> cardiovascular disease. These result</span><span style="white-space:normal;font-family:;" "="">s</span><span style="white-space:normal;font-family:;" "=""> should encourage other physicians to aggressively treat </span><span style="white-space:normal;font-family:;" "="">atherosclerotic cardiovascular disease in their clinic popula</span><span style="white-space:normal;font-family:;" "="">tions.</span> 展开更多
关键词 asymptomatic Cardiovascular disease Coronary Artery Calcium Scan Preventive Medical Therapy Cardiovascular Risk
下载PDF
Preventing Heart Disease via Coronary Artery Calcium Scoring to Make a Definitive Diagnosis of Atherosclerosis
3
作者 David S. Schade Samuel Wann +3 位作者 Martin Hickey Scott Obenshain Jennifer Febbo Robert Philip Eaton 《World Journal of Cardiovascular Diseases》 CAS 2022年第10期457-462,共6页
Purpose: Cardiovascular disease is the number one cause of death in the Western world. The purpose of this manuscript is to compare the benefits and deficiencies of coronary artery calcium scanning versus compute... Purpose: Cardiovascular disease is the number one cause of death in the Western world. The purpose of this manuscript is to compare the benefits and deficiencies of coronary artery calcium scanning versus computer generated risk equations in identifying atherosclerotic cardiovascular disease. These two approaches provide significantly different cardiovascular risk assessments and often lead to therapeutic differences in recommendations from the physician to the patient. Methods: Pertinent medical literature is reviewed concerning both risk assessment approaches (i.e., coronary artery scanning and computer generated risk equations). The strengths and weaknesses of both approaches are discussed, and recommendations are provided based upon available data. Results: Cardiovascular risk equations are simple and readily obtained at no charge by physicians. However, their drawbacks are several, including non-applicability to specific populations, disagreements among different cardiovascular society risk equations, wide ranges of risk outputs (e.g., intermediate 10-year risk is between 5% and 20%), inability to definitively identify coronary artery plaques, and lack of definitive anatomical coronary disease. Alternatively, coronary artery calcium scanning costs approximately $100/scan (if not covered by insurance), requires time and effort by the patient, and exposes the patient to a minimal amount of radiation. However, coronary calcium scanning identifies specific atherosclerotic coronary disease and provides additional information about the anatomical location (i.e., coronary artery) of the atherosclerotic plaque. Conclusion: Based on the published literature, coronary artery calcium scanning is the preferred approach for identifying atherosclerotic cardiovascular disease. Although there are minor drawbacks, overall it provides superior clinical information compared with computer generated risk equations. 展开更多
关键词 asymptomatic Cardiovascular disease Coronary Artery Calcium Scan Preventive Medical Therapy Cardiovascular Risk
下载PDF
Remote ischemic conditioning prevents ischemic cerebrovascular events in children with moyamoya disease:a randomized controlled trial
4
作者 Shuang-Feng Huang Jia-Li Xu +7 位作者 Chang-Hong Ren Nathan Sim Cong Han Yi-Qin Han Wen-Bo Zhao Yu-Chuan Ding Xun-Ming Ji Si-Jie Li 《World Journal of Pediatrics》 SCIE CSCD 2024年第9期925-934,共10页
Background Moyamoya disease(MMD)is a significant cause of childhood stroke and transient ischemic attacks(TIAs).This study aimed to assess the safety and efficacy of remote ischemic conditioning(RIC)in children with M... Background Moyamoya disease(MMD)is a significant cause of childhood stroke and transient ischemic attacks(TIAs).This study aimed to assess the safety and efficacy of remote ischemic conditioning(RIC)in children with MMD.Methods In a single-center pilot study,46 MMD patients aged 4 to 14 years,with no history of reconstructive surgery,were randomly assigned to receive either RIC or sham RIC treatment twice daily for a year.The primary outcome measured was the cumulative incidence of major adverse cerebrovascular events(MACEs).Secondary outcomes included ischemic stroke,recurrent TIA,hemorrhagic stroke,revascularization rates,and clinical improvement assessed using the patient global impression of change(PGIC)scale during follow-up.RIC-related adverse events were also recorded,and cerebral hemodynamics were evaluated using transcranial Doppler.Results All 46 patients completed the final follow-up(23 each in the RIC and sham RIC groups).No severe adverse events associated with RIC were observed.Kaplan-Meier analysis indicated a significant reduction in MACEs frequency after RIC treatment[log-rank test(Mantel-Cox),P=0.021].At 3-year follow-up,two(4.35%)patients had an ischemic stroke,four(8.70%)experienced TIAs,and two(4.35%)underwent revascularization as the qualifying MACEs.The clinical improvement rate in the RIC group was higher than the sham RIC group on the PGIC scale(65.2%vs.26.1%,P<0.01).No statistical difference in cerebral hemodynamics post-treatment was observed.Conclusions RIC is a safe and effective adjunct therapy for asymptomatic children with MMD.This was largely due to the reduced incidence of ischemic cerebrovascular events. 展开更多
关键词 asymptomatic moyamoya disease CHILDREN Remote ischemic conditioning STROKE
原文传递
A novel method for identifying SARS-CoV-2 infection mutants via an epitope-specific CD8^(+)T cell test
5
作者 Congling Qiu Bo Peng +13 位作者 Chanchan Xiao Pengfei Chen Lipeng Mao Xiaolu Shi Zhen Zhang Ziquan Lv Qiuying Lv Xiaomin Zhang Jiaxin Li Yanhao Huang Qinghua Hu Guobing Chen Xuan Zou Xiaofeng Liang 《Biosafety and Health》 CAS CSCD 2024年第3期143-152,共10页
Since the outbreak of the coronavirus disease 2019(COVID-19)epidemic in 2019,the public health system has faced enormous challenges.Tracking the individuals who test positive for severe acute respiratory syndrome coro... Since the outbreak of the coronavirus disease 2019(COVID-19)epidemic in 2019,the public health system has faced enormous challenges.Tracking the individuals who test positive for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is a key step for interrupting chains of transmission of SARS-CoV-2 and reducing COVID-19-associated mortality.With the increasing of asymptomatic infections,it is difficult to track asymptomatic infections through epidemiological surveys and virus whole-genome sequencing.However,due to the cross-reactivity of neutralizing antibodies produced by multiple virus subtypes,neutralizing antibody detection cannot be used to determine whether an individual has a history of infection with a specific subtype of SARS-CoV-2.We recruited 4 human leukocyte antigen A2(HLA-A2)infections,15 individuals who received three doses of inactivated vaccines,and 30 breakthrough infections after vaccination and discussed a case-tracking approach to detect epitope-specific CD8^(+)T cells in the peripheral blood of close contacts,including accurate HLA typing based on ribonucleic acid(RNA)-sequencing and flow cytometry data and the comparison and characterization of SARS-CoV-2 HLA-A2 and HLA-A24 epitope-specific CD8^(+)T cells.From individuals who received three doses of inactivated vaccine,we observed that the CD8^(+)T cell specificity for ancestral epitopes was significantly higher than for mutated epitopes,and the fold change of CD8^(+)T cells corresponding to mutated epitopes relative to ancestral epitopes was less than 1.The enzyme-linked immunospot(ELISpot)results further validate this result.This study forms a“method for understanding the infection history of SARS-CoV-2 subtypes based on the proportion of epitope-specific CD8^(+)T cells in the peripheral blood of subjects”,covering up to 46%of the population,including HLA-A2+and HLA-A24+donors,providing a novel method for SARS-CoV-2 infected case tracing. 展开更多
关键词 asymptomatic coronavirus disease 2019 (COVID-19) EPITOPES Specific CD8^(+)T cell ELISPOT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部